What is it? Why is it important?

Patient and Public Involvement (PPI) refers to research carried out with or by patients and members of the public rather than to, about, or for them.

PPI is the active involvement of patients as partners in research, rather than as study participants.

 

It is important to distinguish between:

  • Patient participants → subjects enrolled in the study
  • Patient partners → contributors to study design, conduct, and dissemination

 

PPI involvement may:

  • Ensure the research question reflects real patient needs, priorities, and lived experience.
  • Ensure the research aligns with what matters most to those affected.
  • Improve relevance and usefulness of study outcomes

 

PPI is not limited to a single phase but integrated throughout:

  • Before the study → co-design, research question, study protocol
  • During the study → advisory role, improving feasibility, compliance
  • After the study → dissemination, return of results

What do I need to do?

As a SP-INV:

  • Start PPI as early as possible
  • Involve patients when shaping the research question
  • Identify patient-relevant outcomes / endpoints
  • Conduct individual patient interviews or a small focus groups. Use structured methods (not ad hoc consultation)
  • Consult a patient advisory board (PAB). A PAB is a group of patients (also caregivers) who advice healthcare establishments, researchers, or other patient relevant companies on how to improve services, treatments, and patient experiences
  • Document how patient input has influenced the research question
  • Clarify level of involvement and define clear roles for patient partners. PPI can occur at different levels, such as informing, consulting, involving, collaborating, or empowering patients
  • Ensure fair compensation and recognition

 

Avoid common pitfalls

  • Late involvement (after key decisions have been made)
  • Tokenistic participation
  • Lack of feedback to patient partners
  • Overburdening patients without support
  • Unclear expectations or roles

 

Today both the Ethics Committee and funders increasingly require PPI involvement during study planning and implementation (e.g. SNSF, IICT programmes).

Where can I get help?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

References

Swiss Clinical Trial Organisation – see in particular

Federal Office of Public Health (FOPH), Switzerland – see in particular

Swiss Cancer Institute – see in particular

University of Basel – see in particular

University of Bern – see in particular

University of Zurich– see in particular

  • PPI - Patient Public Involvement

Swiss National Science Foundation (SNSF) – see in particular

Abbreviations
  • IICT – Investigator Initiated Clinical Trials
  • PAB – Patient Advisory Board
  • PPI – Patient and Public Involvement
  • SP-INV – Sponsor Investigator
  • SNSF – Swiss National Science Foundation
Concept ↦ Protocol ↦ Research Question ↦ Patient and Public Involvement
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Concept ↦ Protocol ↦ Research Question ↦ Patient and Public Involvement